Pact Pharma

Develope of synthetic neo-antigen targeting TILs through T cell isolation platform

placeSan Francisco, California, United States calendar_todayFounded 2016 groups185 employees language pactpharma.com

Registered entities

Investor mix

13 investors on record; lead investors include Vida Ventures, Google Ventures; 1 has since exited.

Investor typeCountShare
Venture capital1185%
Private equity18%
Other / undisclosed18%
Coming soon